Aeovian Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Aeovian Pharmaceuticals, located in the San Francisco Bay Area, is a biopharmaceutical company focused on finding and bringing to market new treatments for rare and age-related illnesses. The company is working on developing drugs that target specific molecular pathways involved in the onset and advancement of diseases, including oxidative, cellular, and environmental stress. Aeovian Pharmaceuticals was established in 2012.
Aeovian Pharmaceuticals has raised $105M across 2 funding rounds on record, the most recent a Series B of $55.0M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aeovian Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Aeovian Pharmaceuticals Funding Rounds
Aeovian Pharmaceuticals raised $50.0M in an undisclosed round announced in Mar 2024.
1.8 years later, a Series B of $55.0M was announced in Dec 2025.
Aeovian Pharmaceuticals Founders and Leadership Team
Contact details for the Aeovian Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Aeovian Pharmaceuticals Funding Compared to Other Biotechnology Startups
Aeovian Pharmaceuticals' latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aeovian Pharmaceuticals in Biotechnology and San Francisco
Companies Similar to Aeovian Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Aeovian Pharmaceuticals Funding FAQs
What does Aeovian Pharmaceuticals do?
Aeovian Pharmaceuticals, located in the San Francisco Bay Area, is a biopharmaceutical company focused on finding and bringing to market new treatments for rare and age-related illnesses. The company is working on developing drugs that target specific molecular pathways involved in the onset and advancement of diseases, including oxidative, cellular, and environmental stress. Aeovian Pharmaceuticals was established in 2012.
How much funding has Aeovian Pharmaceuticals raised?
Aeovian Pharmaceuticals has raised $105M across 2 rounds on record. The most recent is a Series B of $55.0M announced in Dec 2025.
When did Aeovian Pharmaceuticals last raise funding?
Aeovian Pharmaceuticals' most recent funding round on record is a Series B of $55.0M, announced in Dec 2025.
Who founded Aeovian Pharmaceuticals?
FundedIQ lists Stelios Tzannis (Founder) at Aeovian Pharmaceuticals.
Where is Aeovian Pharmaceuticals headquartered?
Aeovian Pharmaceuticals is based in San Francisco, California, United States.
How many employees does Aeovian Pharmaceuticals have?
Aeovian Pharmaceuticals is in the 1-10 employee band.
How does Aeovian Pharmaceuticals' funding compare to other Biotechnology startups?
Aeovian Pharmaceuticals' latest round of $55.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Aeovian Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aeovian Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.